SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-22-003666
Filing Date
2022-03-15
Accepted
2022-03-15 08:30:14
Documents
14
Period of Report
2022-03-15
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K rlyb-20220315.htm   iXBRL 8-K 58111
2 EX-99.1 rlyb-ex99_1.htm EX-99.1 168615
3 GRAPHIC img96626370_0.jpg GRAPHIC 10506
  Complete submission text file 0000950170-22-003666.txt   375639

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rlyb-20220315_pre.xml EX-101.PRE 11459
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rlyb-20220315.xsd EX-101.SCH 2478
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rlyb-20220315_lab.xml EX-101.LAB 13996
8 EXTRACTED XBRL INSTANCE DOCUMENT rlyb-20220315_htm.xml XML 4886
Mailing Address 234 CHURCH STREET SUITE 1020 NEW HAVEN CT 06510
Business Address 234 CHURCH STREET SUITE 1020 NEW HAVEN CT 06510 203- 859-3820
Rallybio Corp (Filer) CIK: 0001739410 (see all company filings)

IRS No.: 851083789 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40693 | Film No.: 22739220
SIC: 2834 Pharmaceutical Preparations